GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Biospecimen and Data Core

$309,126
Joseph B Shrager · Stanford University · U54 · FY2025 · CA

Real-Time Optical Diagnostics of Tissue for PDT Dosimetry and Treatment Character

$309,116
Arjun G Yodh · University Of Pennsylvania · P01 · FY2010 · CA

UNFOLDED PROTEIN RESPONSE IN DRUG SENSITIVITY AND RESISTANCE

$309,064
Linda M Hendershot · St. Jude Children'S Research Hospital · P01 · FY2009 · CA

MOLECULAR BASIS MICROENVIRONMENTAL CELL CYCLE CONTROL

$309,041
University Of Calif-Los Alamos Nat Lab · R01 · FY2000 · CA

Kansas IDeA Network of Biomedical Research Excellence (K-INBRE) - suppl WH

$309,020
Douglas E Wright · University Of Kansas Medical Center · P20 · FY2023 · GM

Stealth Brusatol and Docetaxel-loaded Nanoparticles for Targeted Prostate Cancer Therapy

$309,000
Simeon Kolawole Adesina · Howard University · SC1 · FY2019 · GM

Stellate cells and their progenitor precursors in pancreas cancer progression

$308,990
Paolo Provenzano · University Of Minnesota · R01 · FY2016 · CA

Stellate cells and their progenitor precursors in pancreas cancer progression

$308,990
Paolo Provenzano · University Of Minnesota · R01 · FY2018 · CA

Stellate cells and their progenitor precursors in pancreas cancer progression

$308,990
Paolo Provenzano · University Of Minnesota · R01 · FY2015 · CA

Stellate cells and their progenitor precursors in pancreas cancer progression

$308,990
Paolo Provenzano · University Of Minnesota · R01 · FY2014 · CA

Stellate cells and their progenitor precursors in pancreas cancer progression

$308,990
Paolo Provenzano · University Of Minnesota · R01 · FY2017 · CA

Project 3 - Modulation of host cell biology by KSHV

$308,968
Blossom A Damania · Univ Of North Carolina Chapel Hill · P01 · FY2016 · CA

Project 2: Treating metastatic lung cancer by targeting mutated KRAS with engineered T cells

$308,964
Philip D Greenberg · Fred Hutchinson Cancer Center · P50 · FY2025 · CA

Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.

$308,958
Patricia Yotnda · Baylor College Of Medicine · R01 · FY2011 · CA

The alpha2beta1 Integrin and Tumor Metastasis

$308,958
Mary M. Zutter · Vanderbilt University · R01 · FY2012 · CA

The alpha2beta1 Integrin and Tumor Metastasis

$308,958
Mary M. Zutter · Vanderbilt University · R01 · FY2011 · CA

Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.

$308,958
Patricia Yotnda · Baylor College Of Medicine · R01 · FY2012 · CA

Role of LRP in Astrocytoma Migration

$308,916
Isa M Hussaini · University Of Virginia · R01 · FY2006 · NS

Crucial Microenvironmental Cofactors for Pancreatic Cancer Pathogenesis

$308,894
Eric Collisson · University Of California, San Francisco · R01 · FY2014 · CA

Molecular Basis of Slits as Tumor Suppressors Controlling CXCR4/SDF1 in Breast

$308,832
Lindsay E Hinck · University Of California Santa Cruz · R01 · FY2010 · CA

Micro-RNA-dependent regulation of the UPR

$308,828
J. Alan Diehl · University Of Pennsylvania · P01 · FY2013 · CA

Enhancing Radiation Therapy: Vascular Targeting Agents

$308,814
University Of Florida · R01 · FY2004 · CA

Targeting HMGB1-mediated Autophagy in Cancer Therapy

$308,787
Daolin Tang · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA

Animal Imaging

$308,777
Hongbiao Carl Lekaye · Sloan-Kettering Inst Can Research · P30 · FY2023 · CA

Animal Imaging

$308,777
Hongbiao Carl Lekaye · Sloan-Kettering Inst Can Research · P30 · FY2020 · CA